Won Seog Kim

机构：Samsung (South Korea), Samsung Medical Center, Sungkyunkwan University

发表论文 22 篇 · 总被引 258 次 · h-index 6

代表论文

Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma (2001 · Investigational New Drugs · 被引 138)
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors (2025 · Journal for ImmunoTherapy of Cancer · 被引 42)
CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma (2024 · Blood Advances · 被引 17)
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial (2024 · Haematologica · 被引 14)
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma (2024 · Blood Advances · 被引 13)
Peripheral T-cell lymphoma: From biology to practice to the future (2024 · Cancer Treatment Reviews · 被引 13)